Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Mukherji

Showing results (21-30 of 197) with videos related to

Pageof 20
Sort By:
Current Drug Targets|September 8, 2015
New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate CancerRita Assi, Sally Temraz, Ali Shamseddine, et al.
Biomed Research International|February 25, 2020
Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future DirectionsMalek Kreidieh, Deborah Mukherji, Sally Temraz, et al.
BMJ Case Reports|December 20, 2023
Incidental intra-abdominal synovial sarcomaDina Mistarihi, Anas Obaideen, Deborah Mukherji, et al.
Drugs|May 25, 2012
Management of metastatic castration-resistant prostate cancer: recent advancesDeborah Mukherji, Andrew Eichholz, Johann S De Bono
Critical Reviews in Oncology/Hematology|February 5, 2013
Angiogenesis and anti-angiogenic therapy in prostate cancerDeborah Mukherji, Sally Temraz, David Wehbe, et al.
BMJ Case Reports|April 30, 2015
Diagnosis of double splenic artery pseudoaneurysm: CT scan versus angiographySanaa Badour, Deborah Mukherji, Walid Faraj, et al.
Frontiers in Oncology|May 18, 2026
Cancer care cannot wait: oncology system resilience in the UAE during regional conflict in the gulfHumaid O Al-Shamsi, Deborah Mukherji, Saeed Rafii
Frontiers in Public Health|August 29, 2022
Editorial: The effects of COVID-19 on cancer research methods & strategiesLouis Fox, Richard Sullivan, Deborah Mukherji, et al.
Expert Opinion on Investigational Drugs|January 11, 2012
MDV3100 for the treatment of prostate cancerDeborah Mukherji, Carmel J Pezaro, Johann S De-Bono
Drug Discovery Today|December 27, 2011
Abiraterone acetate: redefining hormone treatment for advanced prostate cancerCarmel J Pezaro, Deborah Mukherji, Johann S De Bono
Pageof 20

Showing results (21-30 of 197) with videos related to

Sort By:
Pageof 20
Current Drug Targets|September 8, 2015
New Compounds Targeting the Androgen Receptor for Treatment of Advanced Prostate CancerRita Assi, Sally Temraz, Ali Shamseddine, et al.
Biomed Research International|February 25, 2020
Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future DirectionsMalek Kreidieh, Deborah Mukherji, Sally Temraz, et al.
BMJ Case Reports|December 20, 2023
Incidental intra-abdominal synovial sarcomaDina Mistarihi, Anas Obaideen, Deborah Mukherji, et al.
Drugs|May 25, 2012
Management of metastatic castration-resistant prostate cancer: recent advancesDeborah Mukherji, Andrew Eichholz, Johann S De Bono
Critical Reviews in Oncology/Hematology|February 5, 2013
Angiogenesis and anti-angiogenic therapy in prostate cancerDeborah Mukherji, Sally Temraz, David Wehbe, et al.
BMJ Case Reports|April 30, 2015
Diagnosis of double splenic artery pseudoaneurysm: CT scan versus angiographySanaa Badour, Deborah Mukherji, Walid Faraj, et al.
Frontiers in Oncology|May 18, 2026
Cancer care cannot wait: oncology system resilience in the UAE during regional conflict in the gulfHumaid O Al-Shamsi, Deborah Mukherji, Saeed Rafii
Frontiers in Public Health|August 29, 2022
Editorial: The effects of COVID-19 on cancer research methods & strategiesLouis Fox, Richard Sullivan, Deborah Mukherji, et al.
Expert Opinion on Investigational Drugs|January 11, 2012
MDV3100 for the treatment of prostate cancerDeborah Mukherji, Carmel J Pezaro, Johann S De-Bono
Drug Discovery Today|December 27, 2011
Abiraterone acetate: redefining hormone treatment for advanced prostate cancerCarmel J Pezaro, Deborah Mukherji, Johann S De Bono
Pageof 20